Rapid Diagnostic Tests (RDTs) are diagnostic assays designed for use at the point-of-care (POC), and can be adapted for use in low-resource settings. An RDT is low-cost, simple to operate and read, sensitive, specific, stable at high temperatures, and works in a short period of time. Rapidly growing medical diagnostics industry, higher demand for preventive management of infectious diseases caused by virus and bacteria worldwide are some of the factors contributing to the growth of global rapid medical diagnostic testing kits market. Rapid medical diagnostics is used for detection of various infectious diseases, caused diabetes, measuring cholesterol levels, testing drug abuse and pregnancy testing.
The global rapid medical diagnostic kits market report estimates the market size (Revenue US$ million – 2014 to 2021) for market segmentation based on diagnostic technologies or assays such as latex agglutination assays, flow-through assays, lateral flow immunoassays (immunochromatographic strip tests), solid-phase assays and their medical applications (hospitals, labs or clinical and home based testing – blood glucose, infection, cholesterol, fertility and pregnancy, substance of abuse, and veterinary testing), and forecasts growth trends (CAGR% – 2017 to 2021).
The global rapid medical diagnostic kits market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global rapid medical diagnostic kits market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global rapid medical diagnostic kits market and included in this report are Abbott Laboratories, Abaxis, Inc., Alere, Inc., Becton Dickinson and Company, BioRad Laboratories, F. Hoffmann La Roche, MegaCor, Trinity Biotech, Zoetis, Inc.